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The effect of cycloheximide (CHX) on denervation-induced acetylcholine receptor (AChR) expression was investigated in chickens one day after 
nerve section, using probe xcess olution hybridization toquantitate AChR ct-subunit gene transcript levels and run-on analysis to measure subunit 
gene activity. The increase in ct-subunit transcripts hat normally follows denervation was prevented when rug treatment was commenced 2 h 
before or after denervation but was not blocked when CHX administration was begun 6 h after the operation. Drug-induced reduction of transcript 
levels results from decreased activity of genes coding for the ~t-, 6-, and y-subunits; in contrast, he transcription rates of several non-receptor genes 
are not affected by CHX. The results suggest that the de novo synthesis of a transcriptional activator is required as a mediating event in the signalling 
pathway linking the plasma membrane and AChR gene expression. 
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1. INTRODUCTION 
Denervat ion of  adult  skeletal muscle induces expres- 
sion of  extra junct ional  cetylchol ine receptor (AChR).  
It is now well establ ished that to a large extent this 
phenomenon is accounted for by a derepression of  
receptor  synthesis upon cessation of  electrical activity 
o f  the p lasma membrane [1-3]. Recent analysis of  the 
mechanisms underlying the increased receptor synthesis 
rate has revealed that denervat ion also results in a 
remarkab le  increase in mRNAs  coding for the in- 
d iv idual  receptor subunits [4-11]. The increased 
message concentrat ions in turn are at least in part  caus- 
ed by enhanced transcr ipt ion rates of  receptor genes 
[1,12]; in the chicken a denervat ion signal reaches the 
genome and activates the t~-, 6-, and 7-subunit  genes 
within 12 h after nerve section [12]. The nature of  this 
signal has remained elusive. For  example,  it is not 
known if denervat ion results in the appearance of  an ac- 
t ivat ing factor or in the loss of  an inhibitor.  Treatment  
of  pr imary  muscle cells with the sodium channel 
b locker tetrodotoxin  results in an increase of  AChR 
prote in and ct-subunit mRNA,  and has been employed 
to analyze the effects of  membrane lectrical activity on 
receptor  gene expression [5,11,13]. Using this in vitro 
model  of  denervat ion,  Duclert et al. [14] have shown 
that inhibit ion of  protein synthesis blocks the 
tetrodotox in- induced rise in a -subuni t  message level 
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and have postulated a requirement for cont inuous pro-  
duct ion of  posit ive regulatory factors in the tetrodotox-  
in response. Their observat ion immediate ly  prompts  
further questions: Does the putat ive regulatory factor 
contro l  transcr ipt  levels by affecting ene activity or by 
transcr ipt  stabi l izat ion? Are other receptor subunit  
messages control led similarly? What  happens in vivo 
upon denervat ion of  skeletal muscle? 
We have investigated the metabol ism of  the AChR 
subunit  messages in denervated chick skeletal muscle. 
Using in vitro transcr ipt  e longat ion ( ' run-on ' )  analysis 
we show that a newly synthesized transact ivator  p otein 
or proteins are required for the denervat ion- induced 
st imulat ion of  AChR et-, 3'-, and tS-subunit genes. 
2. MATERIALS  AND METHODS 
2.1 Denervation 
White Leghorn hatchlings were purchased from Hall's Brothers 
Hatchery (North Brookfield, MA). Section of the sciatic nerve was 
performed as described previously [9]. At the desired time after dener- 
vation animals were killed by ether overdose, and the leg musculature 
below the knee removed and processed immediately. 
2.2. Genomic and complementary DNA probes 
Chicken AChR a-subunit: for transcription elongation ex- 
periments, 1.4 kb of genomic sequence including exons I and II were 
inserted into the polylinker of M 13mp 10 [ 12]. For riboprobe protec- 
tion, pc~7 which comprises exon VII and flanking intronic sequences 
was cloned into Bluescript pSK + (Stratagene, La Jolla, CA); this 
probe has been used to quantitate both mature mRNA and a putative 
splicing intermediate [9,13,14] (see also Fig. 1). Chicken AChR 3'- and 
tS-subunits: 0.5 kbof the 5' region of the 3'-subunit gene i cluding ex- 
on I and 4.8 kb of the 5' portion of the &subunit gene including exons 
I through IV were cloned into Ml3mpl0 to produce complementary 
strands. In addition, the following clones were used: chicken ~°actin: 
full-length cDNA in pBR322, linearized with HindlII; chicken /3- 
tubulin: full-length cDNA in pBR322, linearized with BgllI; chicken 
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MyoD: clone CMD-1 containing a 1.5 kb cDNA insert in pKS+ 
(Stratagene), linearized with EcoRI; chicken c-fos: clone pTZ 19R/ch- 
c-fos, 1.6 kb cDNA inserted into the pTZ19R (USB) vector, linearized 
with KpnI. 
2.3. Quantitation of ct-subunit mRNA 
RNA was extracted, and riboprobe protection assays were perform- 
ed as described previously [11]. 
2.4. Run-on analysis 
Nuclei were isolated and assayed for specific transcript elongation 
as described ina previous paper [12]. To assess the specificity of weak 
signals (such as those seen with AChR subunits in innervated muscle) 
probes were preincubated in solution with the non-radioactive driver 
DNA; such an experiment with ct- and -y-subunit transcripts establish- 
ed that all detectable binding s specific. 
2.5. Drugs 
CHX and actinomycin D were products of Sigma (St. Louis, MO). 
CHX (0.2 mg/kg body weight) was administered i.p. at 4-h intervals; 
a 24-h treatment was survived by over 90% of the animals. For tv2 
studies, single doses of actinomycin D (2 mg/ml) were administered 
i.p. 
3. RESULTS AND DISCUSSION 
Since denervation supersensitivity is largely, if not 
entirely, caused by the cessation of electrical activity of 
the plasma membrane, and since AChR induction, at 
least in part, is mediated by gene activation, a signalling 
pathway must link sarcolemma nd genome. The 
earliest reported changes in receptor metabolism occur 
at about 10-12 h after motor nerve section when the or-, 
~-, and 6-subunit genes become active above 
background level [12]. Transcription rates then increase 
and reach a peak about 36 h after denervation. This in- 
dicates that a minimal number of required transcription 
factors are present at threshold concentration 10h after 
the initial inductive vent. What is happening during 
that latency period? If cessation of action potentials 
were to result directly in activation of a pre-existing fac- 
tor one might expect a faster esponse. More likely, the 
long delay reflects metabolism of a regulatory factor. 
Perhaps an inhibitory protein is not manufactured any 
longer and after 10 h falls below the minimal concentra- 
tion required for function; alternatively (or additional- 
ly), the synthesis of a transactivating factor may be re- 
quired. To distinguish between these mechanisms, the 
effects of the protein synthesis nhibitor CHX were in- 
vestigated. 
3.1. CHX blocks denervation-induced risein a-subunit 
gene transcripts 
When CHX administration is commenced atthe time 
of denervation ct-subunit message l vels 22 h later are 
only 1/17 .of drug-free control, suggesting that protein 
synthesis i  required for the denervation response. In 
contrast, N-CAM mRNA levels (which are not affected 
by denervation - Neville, unpublished results) are only 
slightly reduced (ca 3007o) by a 1-day treatment with 
CHX (data not shown). As a rule, message l vels were 
determined 22 h after nerve section to allow for the 
development of a quantitatively adequate response. 
Omission of the first drug dose (given 2 h before dener- 
vation) did not significantly affect o~-subunit mRNA 
levels 24 h later. However, when the start of the drug 
treatment was delayed from 2-6 h after nerve section a- 
subunit gene expression was no longer strongly in- 
hibited, and later treatment had even less of an effect 
(Fig. 1). This permits the conclusion that a large frac- 
tion of the activator proteins is synthesized during the 
first 6-h period after denervation. 
In principle, denervation-triggered ceptor induc- 
tion could result from the removal of an inhibitory fac- 
tor. It has been shown, for instance, that much of the 
tissue specificity of the expression of the tS-subunit gene 
arises from the presence of a silencer-like element in the 
upstream region [15]. However, CHX would then either 
have no effect or even stimulate receptor gene expres- 
sion which is obviously not the case. Rather, the CHX 
experiments reported here suggest that synthesis of an 
activator protein precedes the denervation-triggered 
receptor up-regulation. This agrees with the identifica- 
tion, in the promoter egions of the chick AChR ct- 
[16-18], q/- (H.-T. Jia and J.S., unpublished), and 6- 
[ 15] genes, of positive-acting elements hat may mediate 
receptor up-regulation not only during differentiation, 
but also following denervation [19]. 
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Fig. 1. Effect of CHX on the steady-state level of u-subunit mRNA. 
Nuclease protection analysis was performed as described inMaterials 
and Methods, with 30 p.g of total RNA and an excess of 10-fold or 
greater of radiolabeled riboprobe. Lane 1: intact ct-subunit probe; 2: 
molecular weight markers (¢~X174/HaelII); 3" CHX (at 0.2 mg/kg 
body weight) administered i.p. in 20-100/zl of phosphate-buffered 
saline 2 h prior to denervation and followed by 4 more injections at 
4-h intervals before sacrifice 22 h post-denervation; 4-6: muscle 
assayed 22 h post-denervation, with drug treatment begun 2 h (4), 6 
h (5), and 10 h (6) after the operation; 7: no CHX treatment; 8: no 
denervation, o CHX. p, i, and m stand for primary transcript, 
putative splicing intermediate [9], and mature message, respectively. 
Exposure was extended to highlight he differences in the level of 'i'. 
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To gain insight into the origin and turnover of the 
transactivator we quantitated the amounts of a-subunit 
specific mRNA and precursor (splicing intermediate 'i'
in Fig. 1) in chronically denervated muscle as a function 
of time after exposure to metabolic inhibitors. Results 
are shown in Fig. 3. Treatment with actinomycin D 
reveals that mature a-subunit mRNA has a half-life of 
about 4 h while the pre-mRNA, in agreement with an 
earlier assessment of a-subunit transcript processing 
rate [9] is much more short-lived. Upon exposure to 
CHX both transcripts decay more slowly, with a t,n of 
one day, suggesting that the decline reflects the rate at 
which transcript replenishment, i.e. receptor a-subunit 
gene activity, diminishes. More precisely, the level of 
some protein required for receptor gene transcription 
decays with a t~/2 of about 24 h. This finding argues 
against a model in which CHX depletes a labile pre- 
existing factor, because CHX treatment begun at the 
time of denervation should then reduce the 22-h dener- 
vation response by only about 5007o instead of 
eliminating it altogether as is actually observed. In addi- 
tion, we have observed that the basal levels of a-subunit 
mRNA in innervated muscle are not affected by 
repeated administration of CHX. Finally, the long 
latency period between the time of denervation and the 
onset of receptor subunit gene transcription (ca l0 h, 
see [12]) is difficult to reconcile with a transcriptional 
activator being targeted irectly by a second messenger 
system. Clearly, the regulatory mechanism ust com- 
prise added variables and features uch as de novo syn- 
thesis of the transactivator. 
Further work will be required to utline the denerva- 
tion response in greater detail. Nevertheless, it is safe to 
state at this point that, in vivo as well as in vitro, syn- 
thesis of an activator protein is required as a link be- 
tween cessation of membrane activity and the derepres- 
sion of acetylcholine r ceptor genes. 
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3.2. CHX blocks activation of AChR subunit genes 
The absence of a denervation response brought about 
by CHX treatment could arise from the failure to 
elaborate ither a necessary transcription factor or a 
protein required to stabilize the message. The pro- 
nounced CHX effect on levels of ct-subunit mRNA 
precursor strongly suggests that transcription is af- 
fected. As an additional test, run-on analysis was per- 
formed. Several genes including those coding for the 
AChR o~-, 3% and 8-subunits were examined. Among 
these, only the AChR subunit genes were significantly 
inhibited in CHX-treated animals. Under the same con- 
ditions total transcriptional ctivity, as measured by in- 
corporation of [32p]UTP, was not significantly af- 
fected. The other tested genes exhibited little change 
compared to the drug-free controls; as can be seen in 
Fig. 2, ~-actin, B-tubulin, c-fos, and MyoD transcrip- 
tion are not much affected. These results indicate that 
the fall in the steady-state l vel or receptor messages i
caused by reduced transcriptional activity rather than 
diminished message stability. It also suggests that the 
regulatory protein may be an activator not only of the 
ct-subunit gene, but also of the genes coding for the ~- 
and 8-subunits, although the CHX-induced inactivation 
of the latter two genes is less severe. The notion of a 
common activator protein is strengthened by the recent 
identification of a consensus equence for positive cis- 
acting elements in the et- and 8-subunit upstream 
regions [15] and by the frequent occurrence of 
CANNTG elements in functionally important regions 
of the ct-, 8-, and 3,-subunit genes ([ 15,16,18] and H.-T. 
J., unpublished observations). It is of course also possi- 
ble that several trans-acting factors are involved; we 
have noticed that the chick AChR -r-subunit gene pro- 
moter displays only limited structural similarity with 
the o~/8 consensus equence (H.-T. J. and J. S., un- 
published results). Finally, these experiments also in- 
dicate that CHX administration does not significantly 
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Fig. 3. Effect of metabolic inhibitors of a-subunit gene transcript 
levels. Intraperitoneal drug treatment of chicks was begun 5-7 days 
after sciatic nerve section. Animals received either a single dose of ac- 
tinomycin D (circles) or multiple injections (repeated at4-h intervals) 
of CHX (triangles). They were sacrificed at the indicated times, and 
total RNA prepared from the shank musculature was analyzed for a- 
subunit pre-mRNA (open symbols) and mature mRNA (filled sym- 
bols) as described in Fig. 1. 
reduce levels and/or activities of nonspecific com- 
ponents of the transcription machinery. 
3.3. Origin of transactivator 
Several regulatory mechanisms are compatible with 
the need for ongoing protein synthesis in the denerva- 
tion response. Among them probably the simplest is 
mediation by a labile protein that doubles as the target 
for second messengers and as a transcription activator. 
Even in innervated muscle this protein would be main- 
tained at a constant concentration by rapid synthesis 
and turnover; upon denervation it would undergo 
modification/activation to perform its task in the 
nucleus. CHX treatment would in such a case lead to 
depletion of the factor; consequently, denervation 
could not lead to activation of receptor genes any 
longer. 
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Fig. 2. Effect of CHX on receptor gene transcription. Transcription elongation was assayed, as described in the methods section, in nuclei isolated 
from innervated (N), denervated (D), and denervated/CHX-treated (C) muscle. 107 nuclei were used in each run-on assay, and 2 x 106 cpm 32p. 
labeled RNA for each hybridization. Results hown are those obtained with ct-, -y-, and 8-specific antisense DNA and the single-stranded vector 
alone, and with double-stranded probes pecific for ~-actin,/3-tubulin, c-fos, MyoD, and with the double-stranded vector pKS +. 
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